Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients

Affiliations

¹ Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group, University Hospital of Cologne, Cologne, Germany.
² Praxis für Hämatologie und Onkologie Cottbus, Cottbus, Germany.
³ BAG MVZ Dr. Vehling-Kaiser GmbH, Landshut, Landshut, Germany.
⁴ Onkologie Ravensburg, Ravensburg, Germany.
⁵ Onkologie und Palliativmedizin Hamburg, Praxis für Hämatologie, Hamburg, Germany.
⁶ Klinikum Lippe Standort Lemgo, Lemgo, Germany.
⁷ Medizinische Klinik III, University Hospital of Rostock, Rostock, Germany.
⁸ Innere Medizin III, University Hospital Schleswig Holstein, Kiel, Germany.
⁹ Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
¹⁰ Division of CLL, Klinik für Innere Medizin III, University Hospital Ulm, Ulm, Germany.
¹¹ Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilian University (LMU), Munich, Germany.

Nadine Kutsch et al. Leuk Lymphoma. 2023 Feb.

. 2023 Feb;64(2):478-482.

doi: 10.1080/10428194.2022.2148210. Epub 2022 Nov 24.

¹ Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group, University Hospital of Cologne, Cologne, Germany.
² Praxis für Hämatologie und Onkologie Cottbus, Cottbus, Germany.
³ BAG MVZ Dr. Vehling-Kaiser GmbH, Landshut, Landshut, Germany.
⁴ Onkologie Ravensburg, Ravensburg, Germany.
⁵ Onkologie und Palliativmedizin Hamburg, Praxis für Hämatologie, Hamburg, Germany.
⁶ Klinikum Lippe Standort Lemgo, Lemgo, Germany.
⁷ Medizinische Klinik III, University Hospital of Rostock, Rostock, Germany.
⁸ Innere Medizin III, University Hospital Schleswig Holstein, Kiel, Germany.
⁹ Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
¹⁰ Division of CLL, Klinik für Innere Medizin III, University Hospital Ulm, Ulm, Germany.
¹¹ Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilian University (LMU), Munich, Germany.

No abstract available

Publication types